Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Harvard Business School
Express Scripts
QuintilesIMS
Argus Health
Citi
AstraZeneca
Medtronic
Chubb

Generated: April 24, 2018

DrugPatentWatch Database Preview

X-TROZINE Drug Profile

« Back to Dashboard

When do X-trozine patents expire, and when can generic versions of X-trozine launch?

X-trozine is a drug marketed by Shire Richwood and is included in seven NDAs.

The generic ingredient in X-TROZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
Summary for X-TROZINE
Drug patent expirations by year for X-TROZINE

US Patents and Regulatory Information for X-TROZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Richwood X-TROZINE phendimetrazine tartrate CAPSULE;ORAL 087394-001 Sep 22, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shire Richwood X-TROZINE L.A. phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 087371-001 Aug 24, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shire Richwood X-TROZINE phendimetrazine tartrate TABLET;ORAL 086552-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shire Richwood X-TROZINE phendimetrazine tartrate TABLET;ORAL 086550-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Moodys
Johnson and Johnson
UBS
Baxter
QuintilesIMS
Cerilliant
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.